Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Mesh.i » - entrée « Rheumatic Diseases »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Rhabdomyolysis < Rheumatic Diseases < Rheumatic Fever  Facettes :

List of bibliographic references indexed by Rheumatic Diseases

Number of relevant bibliographic references: 43.
[0-20] [0 - 20][0 - 43][20-40]
Ident.Authors (with country if any)Title
000034 (2021) Ennio Giulio Favalli [Oman] ; Francesca Ingegnoli [Italie] ; Rolando Cimaz [Italie] ; Roberto Caporali [Italie]What is the true incidence of COVID-19 in patients with rheumatic diseases?
000039 (2021) Roland Duculan ; Deanna Jannat-Khah ; Bella Mehta ; Lisa A. Mandl ; Medha Barbhaiya ; Anne R. Bass ; Carol A. MancusoVariables Associated With Perceived Risk of Contracting SARS-CoV-2 Infection During the COVID-19 Pandemic Among Patients With Systemic Rheumatic Diseases.
000066 (2021) Kim Lauper [Suisse, Royaume-Uni] ; Johannes W J. Bijlsma [Pays-Bas] ; Gerd R. Burmester [Allemagne]Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemic.
000131 (2021) Carmen Magdalena Gamboa-Alonso [Mexique] ; Gabriel Figueroa-Parra [Mexique] ; Dionicio Angel Galarza-Delgado [Mexique]Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie et al.
000140 (2021) Juan Macías [Espagne] ; Paz González-Moreno [Espagne] ; Esther Sánchez-García [Espagne] ; Ram N Morillo-Verdugo [Espagne] ; José J. Pérez-Venegas [Espagne] ; Ana Pinilla [Espagne] ; M Mar Macho [Espagne] ; M Victoria Martínez [Espagne] ; Alejandro González-Serna [Espagne] ; Anaïs Corma [Espagne] ; Luis M. Real [Espagne] ; Juan A. Pineda [Espagne]Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy.
000216 (2021) Eamon Duffy [Nouvelle-Zélande] ; Nicola Arroll [Nouvelle-Zélande] ; Richard Beasley [Nouvelle-Zélande] ; Thomas Hills [Nouvelle-Zélande]Regulatory Action to Protect Access to Hydroxychloroquine for Approved Rheumatic Indications During COVID-19 in New Zealand.
000252 (2021) Piercarlo Sarzi-Puttini [Italie] ; Daniela Marotto [Italie] ; Roberto Caporali [Italie] ; Carlo Maurizio Montecucco [Italie] ; Ennio Giulio Favalli [Italie] ; Franco Franceschini [Italie] ; Michela Fredi [Italie] ; Silvia Balduzzi [Italie] ; Chiara Bazzani [Italie] ; Sara Bongiovanni [Italie] ; Valeria Giorgi [Italie] ; Alberto Batticciotto [Italie] ; Antonella Cappelli [Italie] ; Patrizia Balzarini [Italie] ; Lorenzo Dagna [Italie] ; Silvia Sartorelli [Italie] ; Viviana Ravagnani [Italie] ; Silvia Tamanini [Italie] ; Sonia Farah [Italie] ; Paola Faggioli [Italie] ; Laura Castelnovo [Italie] ; Alfredo Maria Lurati [Italie] ; Massimo Galli [Italie] ; Fausto Salaffi [Italie]Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study.
000418 (2021) Wenhui Xie [République populaire de Chine] ; Yu Wang [République populaire de Chine] ; Zhuoli Zhang [Oman]Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?
000599 (2021) Sara Monti [Oman] ; Carlomaurizio Montecucco [Italie]Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al.
000619 (2021) Zeyad A. Alzahrani [Arabie saoudite] ; Khalid Abdullah Alghamdi [Arabie saoudite] ; Ahmed Saeed Almaqati [Arabie saoudite]Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases.
000642 (2021) Dominik Majewski [Pologne] ; Katarzyna Anna Majewska [Pologne] ; Monika Naskr Cka [Pologne] ; Bogna Grygiel-G Rniak [Pologne]Chloroquine and hydroxychloroquine - safety profile of potential COVID-19 drugs from the rheumatologist's perspective.
000669 (2021) Gillian E. Fitzgerald [Canada] ; Sinead Maguire [Irlande (pays)] ; Nigil Haroon [Canada]COVID-19: What Do Rheumatologists Need to Know?
000674 (2021) Hussain Ahmed Raza [Pakistan] ; Javeria Tariq [Pakistan] ; Vikas Agarwal [Inde] ; Latika Gupta [Inde]COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases.
000691 (2021) Kieran Murray [Irlande (pays)] ; Sean Quinn [Irlande (pays)] ; Matthew Turk [Irlande (pays)] ; Anna O'Rourke [Irlande (pays)] ; Eamonn Molloy [Irlande (pays)] ; Lorraine O'Neill [Irlande (pays)] ; Ann Barbara Mongey [Irlande (pays)] ; Ursula Fearon [Irlande (pays)] ; Douglas J. Veale [Irlande (pays)]COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population.
000878 (2020) Khalid Eljaaly [États-Unis] ; Kasim Huseein Alireza [Arabie saoudite] ; Samah Alshehri [États-Unis] ; Jaffar A. Al-Tawfiq [États-Unis]Hydroxychloroquine safety: A meta-analysis of randomized controlled trials.
000883 (2020) Lucile Grange [France] ; Philippe Guilpain [France] ; Marie-Elise Truchetet [France] ; Jean-Luc Cracowski [France]Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review.
000962 (2020) Burhan Fatih Kocyigit [Turquie] ; Mazlum Serdar Akaltun [Turquie] ; Ahmet Riza Sahin [Turquie]YouTube as a source of information on COVID-19 and rheumatic disease link.
000977 (2020) Daniela Marotto [Italie] ; Piercarlo Sarzi-Puttini [Italie]What is the role of rheumatologists in the era of COVID-19?
000A09 (2020) Jinoos Yazdany ; Alfred H J. Kim [États-Unis]Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
000B02 (2020) Emire Seyahi [Turquie] ; Burc Cagri Poyraz [Turquie] ; Necdet Sut [Turquie] ; Selma Akdogan [Turquie] ; Vedat Hamuryudan [Turquie]The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey.
000C08 (2020) Eugeniusz J. Kucharz [Pologne]Should coronavirus disease 2019 concern rheumatologists?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Rheumatic Diseases" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Rheumatic Diseases" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Rheumatic Diseases
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021